Published in Cell Immunol on February 01, 1984
Cultured human epidermal allografts are not rejected for a long period. Arch Dermatol Res (1986) 0.86
Demonstration of T6+ and DR+ cells in human placenta. Arch Dermatol Res (1987) 0.77
Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol (2001) 8.31
GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature (1992) 7.41
Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity (2000) 4.44
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med (1996) 3.82
Obliquity-paced Pliocene West Antarctic ice sheet oscillations. Nature (2009) 3.42
Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature (1984) 3.32
Novel endotheliotropic herpesviruses fatal for Asian and African elephants. Science (1999) 3.30
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest (2000) 3.20
Cell lineages of the embryo of the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A (1978) 2.95
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest (1999) 2.95
Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. Anal Biochem (2001) 2.73
Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med (2000) 2.38
Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol (1983) 1.98
The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol (1999) 1.93
Experimental production of antibodies against stratum corneum keratin polypeptides. Arch Dermatol Res (1980) 1.87
Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng (1988) 1.87
Attempt to protect rabbits against experimental syphilis by passive immunization. Br J Vener Dis (1973) 1.68
Clinical and pathological findings of a newly recognized disease of elephants caused by endotheliotropic herpesviruses. J Wildl Dis (2000) 1.66
Porokeratosis and immunosuppression. Eur J Dermatol (1999) 1.62
Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group. Br J Psychiatry (1999) 1.62
Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J Clin Invest (2001) 1.61
Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis (1985) 1.54
Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo. Circ Res (1999) 1.54
External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol (1997) 1.53
Antinuclear autoantibodies in Swiss mice thymectomized at birth. Nature (1967) 1.50
PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol (1980) 1.46
[Acne scars: epidemiology, physiopathology, clinical features and treatment]. Ann Dermatol Venereol (2006) 1.40
Characterization of facteur thymique sérique (FTS) in the thymus. I. Fixation of anti-FTS antibodies on thymic reticulo-epithelial cells. Clin Exp Immunol (1980) 1.40
[Oral photochemotherapy in vitiligo (author's transl)]. Ann Dermatol Venereol (1979) 1.39
[Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid]. Ann Dermatol Venereol (1999) 1.39
Clinical picture: eyelid metastasis. Lancet (2001) 1.39
Antibody to soluble nuclear antigens in dogs (German shepherd) with a lupus like syndrome. Dev Comp Immunol (1978) 1.28
Immunohistochemical study of CD34-positive dendritic cells of human dermis. Am J Dermatopathol (1996) 1.25
Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang (1971) 1.23
Giant colonic diverticula--three distinct entities. Report of a case. Dis Colon Rectum (1988) 1.22
In Xenopus laevis, the product of a developmentally regulated mRNA is structurally and functionally homologous to a Saccharomyces cerevisiae protein involved in translation fidelity. Mol Cell Biol (1993) 1.18
Keratin polypeptides distribution in normal and diseased human epidermis and oral mucosa. Immunohistochemical study on unaltered epithelium and inflammatory, premalignant and malignant lesions. Virchows Arch A Pathol Anat Histol (1980) 1.18
Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients. J Virol (1998) 1.18
Human dendritic Langerhans cells generated in vitro from CD34+ progenitors can prime naive CD4+ T cells and process soluble antigen. J Immunol (1995) 1.16
Autism and family home movies: preliminary findings. J Autism Dev Disord (1991) 1.16
Vasopressin and angiotensin II receptors in rat aortic smooth muscle cells in culture. Am J Physiol (1983) 1.16
Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa. J Virol (1996) 1.14
Investigation of a specific IgM antibody test in neonatal congenital syphilis. Br J Vener Dis (1970) 1.14
Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children. J Immunol (1993) 1.14
Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J Leukoc Biol (1999) 1.13
Gi2-mediated activation of the MAP kinase cascade. Mol Biol Cell (1995) 1.12
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus. Br J Dermatol (1977) 1.11
Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase. Proc Natl Acad Sci U S A (2001) 1.10
Interactions of proteins and lipids: structure and polymorphism of protein-lipid-water phases. Nature (1969) 1.09
Interleukin-6 in normal skin and psoriasis. Acta Derm Venereol (1992) 1.09
[Immunofluorescence studies of serum autoantibodies with respect to the constituents of the epidermis of burned patients]. Experientia (1968) 1.09
Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression. Dermatologica (1987) 1.08
Congenital self-healing histiocytosis (Hashimoto-Pritzker). An ultrastructural and immunohistochemical study. Cancer (1988) 1.07
Cytoplasmic localization of FTS (facteur thymique sérique) in thymic epithelial cells. An immunoelectronmicroscopical study. Thymus (1980) 1.07
Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1. AIDS Res Hum Retroviruses (1997) 1.07
Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. J Invest Dermatol (1983) 1.06
Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol Rev (2001) 1.06
Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements. J Immunol Methods (2000) 1.06
Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J Leukoc Biol (1998) 1.05
CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. J Immunol (1997) 1.05
Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin. Br J Dermatol (1986) 1.05
Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur J Immunol (1994) 1.04
The cellular anatomy of embryos of the nematode Caenorhabditis elegans. Analysis and reconstruction of serial section electron micrographs. Dev Biol (1978) 1.03
Comparative morphology and paleobiology of Middle Pleistocene human remains from the Bau de l'Aubesier, Vaucluse, France. Proc Natl Acad Sci U S A (2001) 1.02
An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses. Vaccine (2007) 1.02
Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts. Exp Dermatol (2004) 1.01
Cloning of MMP-26. A novel matrilysin-like proteinase. Eur J Biochem (2000) 1.01
Epidermal and mucosal dendritic cells and HIV1 infection. Pathol Res Pract (1994) 1.01
Re-emergence of brucellosis in cattle in France and risk for human health. Euro Surveill (2012) 1.00
[Scleroderma en coup de sabre with homolateral chronic glaucoma (author's transl)]. Ann Dermatol Venereol (1977) 1.00
Oral photochemotherapy in the treatment of lichen planus (LP). Clinical results, histological and ultrastructural observations. Br J Dermatol (1978) 1.00
Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol (1995) 1.00
Immunocytochemical evidence for a possible role of cross-linked keratinocyte envelopes in stratum corneum cohesion. J Histochem Cytochem (1991) 1.00
Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin. Eur J Dermatol (1999) 0.99
Identification of a human guanine nucleotide-releasing factor (H-GRF55) specific for Ras proteins. Oncogene (1993) 0.99
PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol (1979) 0.99
[Australia antigen, virus hepatitis and periarteritis nodosa]. Presse Med (1970) 0.99
Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol (1995) 0.98
Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers. Contact Dermatitis (1994) 0.98
Transforming growth factor-beta in the regulation of the immune response. Clin Immunol Immunopathol (1992) 0.98
High viral load and CD4 lymphopenia in rhesus and cynomolgus macaques infected by a chimeric primate lentivirus constructed using the env, rev, tat, and vpu genes from HIV-1 Lai. Virology (1996) 0.97
Cyclic nucleotide phosphodiesterase of Dictyostelium discoideum and its glycoprotein inhibitor: structure and expression of their genes. Dev Genet (1991) 0.97
[Maternally-transmitted severe neonatal aphthosis]. Ann Dermatol Venereol (1982) 0.97